Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02589964 · ClinicalTrials.gov registry record · Phase 1
Probiotics in the Reduction of Antibiotic Associated Diarrhea
A Phase 1 study, sponsored by TriHealth.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT02589964 is a Phase 1 study that was terminated before completion, run by TriHealth. The registered enrollment target is 1 participants.
The verdict
NCT02589964, a Phase 1 study, was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The study will evaluate the effectiveness of probiotic therapy in reducing the incidence of antibiotic associated diarrhea (AAD) and Clostridium difficile associated diarrhea (CDAD) in pneumonia patients.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Florajen-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02589964
The ClinicalTrials.gov registry entry for NCT02589964 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02589964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02589964 about?
NCT02589964 is a clinical study titled "Probiotics in the Reduction of Antibiotic Associated Diarrhea". The study will evaluate the effectiveness of probiotic therapy in reducing the incidence of antibiotic associated diarrhea (AAD) and Clostridium difficile associated diarrhea (CDAD) in pneumonia patients.
What is the current status of trial NCT02589964?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2015-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02589964?
The interventions under investigation include: Placebo (OTHER), Florajen-3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02589964?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.